“dana-farber-cancer-institute” Archives

Entry Author Date Location
Report: UCSF Strikes $85M Deal With Pfizer to Develop Biotech Drugs 11/15/10 San Francisco
Avila Therapeutics Pursuing Rival to Lung Cancer Drug in Dana-Farber Lawsuit 11/12/10 Boston
Complete Genomics Goes Public, 23andMe Raises $22M, Genomic Health’s Dx Vision, & More Bay Area Life Sciences News 11/12/10 San Francisco
Bay Area Biotech Startup at Odds with Dana-Farber and Novartis Over Cancer Drug Rights 10/28/10 Boston
Dana Farber Gets $33M from Sanofi, Astellas Backs DecImmune, Ironwood Sells Microbia, & More Boston-Area Deals News 09/29/10 Boston
Dana Farber Gets $33M in Sanofi Deal 09/23/10 Boston
Aileron Inks Deal with Roche, Worth Up to $1.1B, to Develop Stapled Peptide Drugs 08/24/10 Boston
On-Q-ity, Led by Former Genzyme Exec, Takes on “Diagnostic Black Hole” in Cancer 07/07/10 Boston
Genentech’s Souped-Up Herceptin: The Odyssey Toward a More Powerful Breast Cancer Drug 06/14/10 San Francisco
Sage Bionetworks Snaps Up $6.7M Grant to Train Young Network Biologists 02/23/10 Seattle
Biogen Drops Facet Bid, Aveo Reveals IPO Ambitions, Pfizer Partners with Adimab, & More Boston-Area Life Sciences News 12/23/09 Boston
Breast Cancer “Smart Bomb” Drug From Roche, ImmunoGen Passes Important Trial 12/12/09 Boston
Supercharged Herceptin Nears Pivot Point, as ImmunoGen, Roche Await Data on Breast Cancer “Smart Bomb” 12/07/09 Boston
Aileron’s New Class of Drugs Shown to Get Inside Cells to Block Prime Cancer Target 11/11/09 Boston
Tokai Pushes Edge With Three-Pronged Attack on Prostate Cancer 11/10/09 Boston
HubSpot Spots $16M, Synageva BioPharma Secures $12M, Currensee Sews Up $6M, & More Boston-Area Deals News 10/23/09 Boston
Nuclea Nabs $3.4M Deal 10/22/09 Boston
Fate Therapeutics Growing Fast on “Industrialized” Stem Cell Technology 09/30/09 National
Helicos Biosciences, Running Low on Cash, Snaps Up $10M Lifeline 09/16/09 Boston
Biogen Idec Faces Suit From Partner Elan, Genzyme Wins European Approval for Stem-Cell Boosting Drug, Alnylam Teams with Tekmira, & More Boston-Area Life Sciences News 08/12/09 Boston
Genzyme Faces Lawsuit and Competition, Vertex Gathers More Cash for Telprevir, Cardiorobotics Corrals $11.6M, & More Boston-Area Life Sciences News 08/05/09 Boston
Vertex Scores $105M For Asian Telaprevir Rights, Avila Avails Itself of $30M, IBM Picks Up Ounce Labs, & More Boston-Area Deals News 07/31/09 Boston
MSM Protein Technologies Scores Antibody-Drug Discovery Partnerships 07/30/09 Boston
Aveo Pieces Together a Plan to Rival Big Boys of Cancer Drug World 06/29/09 Boston
Aileron Snags $40M From Quartet of Pharma Giants to Develop New Class of Drugs 06/08/09 Boston
Mass Medical Angels Forms to Invest in Life Sciences Startups-And Get the Ball Rolling for VCs 04/03/09 Boston
Funding Pool Deep for Still River, Cuts in the Offing for Epix and Synta, FDA Approvals Granted for Hologic, & More Boston-Area Life Sciences News 03/18/09 Boston
$8M for NKT Therapeutics 03/16/09 Boston
Agios Pharmaceuticals Forges Ahead With Lab to Starve Cancer Cells 11/24/08 Boston
Shire Settles TKT Suit, Roche and Ensemble Together Again, BSX Backs Neuromodulation Startup, & More Boston-Area Life Sciences News 11/13/08 Boston
Page 2 of 3 « previous page · next page »